Nabriva Therapeutics plc
NBRV
NASDAQ Capital Market1.42
USD
+0.01
- -
Total Valuation
Nabriva Therapeutics plc carries a market capitalization of 4.55M, placing it among publicly traded companies globally.
| Market Cap | 4.55M |
| Enterprise Value | N/A |
Stock Price Statistics
Nabriva Therapeutics plc's stock has declined approximately -65.95785% over the past 52 weeks. The 50-day moving average sits at 1.55, while the 200-day moving average is 1.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | -65.95785% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 1.78 |
| Average Volume (20 Days) | N/A |
Stock Splits
Nabriva Therapeutics plc's most recent stock split took place on September 16, 2022 with a 25:1 split ratio.
| Last Split Date | 9/16/2022 |
| Split Ratio | 25:1 |